| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $68.2M | +12.0% |
| R&D Expense | $5.7M | +3.0% |
| SG&A Expense | $14.7M | +6.5% |
| Operating Income | $4.7M | +157.1% |
| Pre-tax Income | $5.4M | +184.3% |
| Income Tax | $300K | +41.5% |
| Net Income | $5.1M | +202.4% |
| EPS (Basic) | $0.17 | +183.3% |
| EPS (Diluted) | $0.16 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $4.9M | +12.9% |
| Inventory | $454K | +15.5% |
| Current Assets | $41.9M | +55.9% |
| Total Assets | $77.7M | +19.6% |
| Current Liabilities | $12.3M | +1.9% |
| Long-term Debt | $114K | -80.7% |
| Total Liabilities | $13.9M | +2.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.3M | +47.9% |
| Capital Expenditures | $18K | -33.3% |
| Investing Cash Flow | -$18K | +33.3% |
| Financing Cash Flow | $3.9M | +143.4% |
| Free Cash Flow | $9.3M | +48.3% |
| +166.7% |
| Stockholders' Equity |
| $63.8M |
| +24.1% |